t34classic

Author Archives

There Was a post about CloudMD a Canadian company a few days back it seems to have disappeared or maybe I do not know where to look. But I am wondering if anyone had taken a look at it and what your thoughts were. thanks

Recent Author Comments

On Microblog: Travis book recomendation

https://www.amazon.com/100-Baggers-Stocks-100-1/dp/1621291650/ref=tmm_pap_swatch_0?_encoding=UTF8&qid=&sr=[...]

Go to Comment »
On COVID-19: Keeping Up With the Current State of the Pandemic

Please supply links to the successful treatment reports you quote, the scenario you describe paints the picture of a conspiracy and I would be interested in these reports, I have experience with the manufacture of medical devices, drugs and interactions [...]

Go to Comment »
On Quadruple Digit Gains from "End of Bitcoin?"

I am going to use all my bitcoins to buy beef before they are both gone[...]

Go to Comment »
On Friday File: Benchmarked Returns, Some Clunker Updates, and Coinbase

There was an article in Barrons about a model put together by a group of economists that sought to determine what stocks were more akin to gambling then investing, they presented a list of ten stocks that their model identified, NNDM was on the list. I see[...]

Go to Comment »
On "Apple Patent Could Ignite 20-Cent Stock?" What's Jason Simpkins talking about?

Right book wrong author. I will happily plead guilty to an aging brain and a lifetime of reading making it hard to keep things straight. Yes the technology and the surveillance it represented is a bit creepy. We now accept intrusions into our lives that 30[...]

Go to Comment »
On "Apple Patent Could Ignite 20-Cent Stock?" What's Jason Simpkins talking about?

VSBLTY: reviewing their website last fall and the investor brochure, I could not help but to think of Aldous Huxley's 1984 with the TV' that watched you and could not be turned off. I did buy some shares and it has been enjoyable watching the (now slowing)[...]

Go to Comment »
On Friday File: The SPAC Heard 'Round the (Newsletter) World... plus, a new Gumshoe Portfolio is born

The new "portfolio" sounds like a great idea, if I am not careful I may learn something.[...]

Go to Comment »
On Microblog: Hi Travis - could you also start an options service

With all do respect this works out well the way it is, it must be a good amount of work to publish what comes out if the Stock Gumshoe each week and there seems to be enough information provided that you can take it in the direction you want to go, any [...]

Go to Comment »
On Microblog: IPO's

Next door seems to be a often utilized asset in my section of the world, and a definite plus when thinking about locale resources, thanks for posting this is something that I will keep an eye on.[...]

Go to Comment »
On Microblog: LexaGene (LXXGF) - Molecular diagnostics company with great upside due to high margin "razor blade" business model

Could be I will have to reread it but their technical issues seemed to be more than cleaning for covid. In fact the way I read it had nothing to do with covid at all. Honestly testing for just covid would probably be an easy avenue, you would have an in[...]

Go to Comment »
On Microblog: LexaGene (LXXGF) - Molecular diagnostics company with great upside due to high margin "razor blade" business model

These are my thoughts I have some knowledge with analytical instrumentation. Reading through their last filing with a management discussions they mentioned a couple of areas that caused me some concern: They seemed to be uncertain about cleaning procedures[...]

Go to Comment »
On What are those "Three Hidden SaaS Stocks with 1,000% Potential?"

GMGI I was intrigued good price point in a new market. I read through most of the 10 Q filed in mid December kind of made my head spin. I will sit this one out I think.[...]

Go to Comment »
On Friday File: SPACs, Big news from GAN, and a new Watchlist Stock

Thanks for posting the link[...]

Go to Comment »
On Microblog: Discussion page for Arch Therapeutics (ARTH)

yes thanks for the post, a little encouragement has been needed.[...]

Go to Comment »
On Microblog: Discussion page for Arch Therapeutics (ARTH)

Thank you for reaching out to Arch, the lack of input from Arch is (I will understate it as unfortunate.) Iit would be my best guess that they are having a difficult time moving the process from sample size to commercial quantities. I can see a scenario w[...]

Go to Comment »

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info